Atrion Corp ATRI:NASDAQ

RT Quote | NASDAQ | USD
Last | 02/26/21 EST
624.90quote price arrow down-15.10 (-2.36%)
Volume
5,017
52 week range
567.00 - 755.00

...

Loading . . .

KEY STATS

  • Open640.85
  • Day High640.85
  • Day Low624.90
  • Prev Close624.90
  • 52 Week High755.00
  • 52 Week High Date03/25/20
  • 52 Week Low567.00
  • 52 Week Low Date11/24/20
  • Market Cap1.144B
  • Shares Out1.83M
  • 10 Day Average Volume0.01M
  • Dividend7.00
  • Dividend Yield1.12%
  • Beta0.10
  • 1 Year % Change-1.09

RATIOS/PROFITABILITY

  • EPS (TTM)17.73
  • P/E (TTM)35.24
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)48.827M
  • ROE (MRQ)13.94%
  • Revenue (MRQ)149.81M
  • Gross Margin (MRQ)45.21%
  • Net Margin (MRQ)21.89%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date03/12/2021
  • Div Amount1.75
  • Split Date-
  • Split Factor-

Latest Atrion Corp News

There is no recent news for this security.

Latest ATRI News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Atrion Corporation (Atrion) is engaged in developing and manufacturing products, primarily for medical applications. The Company's medical products range from fluid delivery devices to ophthalmic and cardiovascular products. Its fluid delivery products include valves that promote infection control and needle safety. It has developed a range of valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, intravenous...
Emile Battat
Chairman
David Battat
Chief Executive Officer
Jeffery Strickland
Chief Financial Officer
Address
1 Allentown Pkwy
Allen, TX
75002-4206
United States